These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6734041)

  • 1. Hepatic drug metabolism and physical fitness.
    Boel J; Andersen LB; Rasmussen B; Hansen SH; Døssing M
    Clin Pharmacol Ther; 1984 Jul; 36(1):121-6. PubMed ID: 6734041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute and chronic exercise on hepatic drug metabolism.
    Døssing M
    Clin Pharmacokinet; 1985; 10(5):426-31. PubMed ID: 3899456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.
    Krishnaswamy K; Kalamegham R; Naidu NA
    Br J Clin Pharmacol; 1984 Feb; 17(2):139-46. PubMed ID: 6704283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
    Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE
    Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver function in physically trained subjects: galactose elimination capacity, plasma disappearance of indocyanine green, and aminopyrine metabolism in long-distance runners.
    Ducry JJ; Howald H; Zysset T; Bircher J
    Dig Dis Sci; 1979 Mar; 24(3):192-6. PubMed ID: 456207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Drug metabolism in disease.
    Hepner GW
    Lancet; 1974 May; 1(7865):1048-9. PubMed ID: 4133721
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
    J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of H2 receptor antagonists on hepatic drug metabolism.
    Henry DA; Langman MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():85-7. PubMed ID: 6119788
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive assessment in vivo of hepatic drug metabolism in health and disease.
    Vesell ES
    Ann N Y Acad Sci; 1984; 428():293-307. PubMed ID: 6378027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipyrine clearance, aminopyrine N-demethylase, and bilirubin UDP-glucuronyl transferase activity in patients with amoebic liver abscess.
    Narang AP; Datta DV; Mathur VS
    Biopharm Drug Dispos; 1982; 3(1):39-45. PubMed ID: 7082778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of aminopyrine in chick embryo hepatic cell culture: effects of competitive substrates and carbon monoxide.
    Poland A; Kappas A
    Mol Pharmacol; 1971 Nov; 7(6):697-705. PubMed ID: 5169931
    [No Abstract]   [Full Text] [Related]  

  • 15. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hepatic microsomal reserve in patients with cirrhosis. Studies using aminopyrine as model drug.
    Piken E; Hepner GW
    J Lab Clin Med; 1979 Dec; 94(6):947-54. PubMed ID: 501215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipyrine excretion and aminopyrine breath test: use and significance in the assessment of liver function].
    Gugler R
    Z Gastroenterol; 1987 Mar; 25 Suppl 2():51-6. PubMed ID: 3590907
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of hepatic drug metabolism by isolated perfused liver in situ.
    Benzi G; Berté F; Crema A
    J Pharm Sci; 1967 Jul; 56(7):893-5. PubMed ID: 4962274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.